Cleansing System Facilitates Colonoscopy Bowel Preparation

Pure-Vu integrates easily with most standard and slim endoscopes, and fits easily into the clinical workflow.

The system includes a control unit with sensing technology that prevents clogging during evacuation, a foot pedal for activation, and the disposable Pure-Vu Sleeve, with multiple irrigation jets spaced on the rim perimeter to efficiently clean the mucosal surface and two evacuation ports to increase removal of colon content. A low friction hydrophilic coating aids smooth advancement of the sleeve into the colon. In clinical studies, the system significantly increased the number of patients with an adequate cleansing level, based on the Boston Bowel Preparation Scale Score, a validated assessment instrument.

“The Pure-Vu System continues to demonstrate outstanding cleansing performance in poorly prepped colons, including the statistically significant improvement in colon cleanliness in hospitalized patients, as recently demonstrated,” said Tim Moran, CEO of Motus GI, commenting on FDA approval of the system. “We are now well positioned to execute our planned commercial launch of the Pure-Vu System this year and advance toward our goal of establishing the Pure-Vu System as a new standard of care in key endoscopy segments.”

“Inadequate bowel preparation prior to colonoscopy remains an unmet need that affects a significant percentage of patients’ ability to receive a complete and high-quality exam. This often leads to canceled, delayed and aborted procedures, resulting in prolonged hospitalizations and increased costs for both patients and providers,” said gastroenterologist Jason Samarasena, MD, of the University of California Irvine (UCI; USA). “The Pure-Vu System provides an important solution to address the significant clinical challenges and inefficiencies associated with inadequate prep.”

Challenges with bowel preparation for inpatient colonoscopy represent a significant area of unmet need that directly affects clinical outcomes and increases the cost of care in a market segment that comprises approximately 1.5 million annual procedures in the United States, and approximately four million annual procedures worldwide.

Related Links:
Motus GI